Kintara Therapeutics Inc. Gains 20.32%
Thu, Jul 06, 2023 at 07:33 PM
Kintara Therapeutics Inc. (KTRA:NASDAQ) jumped higher at $5.21, a gain of 20.3%. On Thu, Jul 06, 2023, KTRA:NASDAQ touched a New 2-Week High of $5.21. The stock appeared on our News Catalysts scanner on Fri, Jun 30, 2023 at 02:11 PM in the 'BIOTECH' category. From Thu, Jun 22, 2023, the stock recorded 44.44% Up Days and 50.00% Green Days
About Kintara Therapeutics Inc. (KTRA:NASDAQ)
Kintara Therapeutics Inc is engaged in the development of novel cancer therapies for patients with unmet medical needs.
Top 10 Gainers:
- EdtechX Holdings Acquisition Corp. (EDTX:NASDAQ), 93.83%
- Caribou Biosciences Inc. (CRBU:NASDAQ), 45.59%
- Mullen Automotive Inc. (MULN:NASDAQ), 29.02%
- Genius Sports Limited (GENI:NYSE), 25.65%
- Barnes & Noble Education, Inc. (BNED:NYSE), 25.61%
- Aethlon Medical, Inc. (AEMD:NASDAQ), 25%
- Eco Wave Power Global AB (publ) (WAVE:NASDAQ), 23.42%
- Aeglea BioTherapeutics, Inc. (AGLE:NASDAQ), 20.93%
- Kintara Therapeutics Inc. (KTRA:NASDAQ), 20.32%
- Myomo, Inc. (MYO:NYSEMKT), 19.37%